InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.91
(
-0.04%
)
US TECH 100
19,240.00
(
0.13%
)
Dow Jones
39,096.43
(
-0.08%
)
Brent Oil
85.32
(
1.00%
)
Bitcoin
61,650.00
(
1.38%
)
Post# of 34625
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

pharmeng

Send PM Follow Ignore
Followers 1
Posts 61
Boards Moderated 0
Alias Born 12/29/2011

pharmeng

Re: None

Wednesday, 06/15/2016 7:09:39 PM

Wednesday, June 15, 2016 7:09:39 PM

Post# of 34625
Some clinical evidence that FRa is a viable target in ovarian cancer.

Immunogen reported phase 1 results for their FRa targeted ADC in May.
The median PFS and ORR in patients with high/medium FRa expression was 6.7 mo and 44% compared to 4.2 mo and 17% in pateints with low FRa.

I think this bodes well for the TPIV/Astra combo study since Immunogen showed some correlation between FRa expression level and response rate. TPIV has only shown immune response in their trials so far, and no efficacy, but this is helpful data to show the target may work.



Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MRKR News
More MRKR News
InvestorsHub NewsWire

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!